Home » U.S. FDA Brings Drugs to Market Faster Than EMA, Canada: Study
U.S. FDA Brings Drugs to Market Faster Than EMA, Canada: Study
June 7, 2012
The U.S. Food and Drug Administration (FDA) is approving drugs faster than its regulatory peers in Europe and Canada, a new study finds, challenging criticism that the U.S. agency harps on safety at the expense of timely reviews.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor